Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
CYP2J2 encodes a member of the cytochrome P450 superfamily of enzymes. Zusätzlich bieten wir Ihnen CYP2J2 Kits (3) und CYP2J2 Proteine (3) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 68 products:
Human Monoclonal CYP2J2 Primary Antibody für ELISA, WB - ABIN560550
Pearson, Warren, Barrett, Khan: Detection of EETs and HETE-generating cytochrome P-450 enzymes and the effects of their metabolites on myometrial and vascular function. in American journal of physiology. Endocrinology and metabolism 2009
Show all 4 Pubmed References
Study found a significant interaction between CYP2J2- rs890293 and PPAR -gamma (zeige PPARG Antikörper)- rs1805192 and participants with GT or TT of rs890293 and CG or GG of rs1805192 genotype have the highest late-onset Alzheimer's disease risk, compared to participants with GG of rs890293 and CC of rs1805192 genotype.
dysregulation of the CYP (zeige PPIG Antikörper) epoxyeicosanoid pathway is a key pathological consequence of NASH (zeige SAMSN1 Antikörper)
CYP2J2 is widely expressed in tissues, especially heart, vascular smooth muscle, salivary glands and placenta. Recent studies have shown that overexpression of CYP2J2 in vivo reverses several pathological processes in animals, including hypertension and other cardiovascular pathologies and insulin (zeige INS Antikörper) resistance.
Homocysteine (Hcy) facilitated cytochrome P-450 (zeige CYP Antikörper) CYP2J2 (CYP2J2) upregulation in hepatocellular carcinoma (HCC (zeige FAM126A Antikörper)) cells by DNA demethylation.
Endothelial overexpression of CYP2J2 significantly changed oxylipin profiles.
MAPK (zeige MAPK1 Antikörper) signaling pathway was involved in the up-regulation of CYP2J2 levels by glutamate (zeige GRIN1 Antikörper) in U251 cells.
Data show that CYP2J2 gene delivery reduced vessel wall thickening.
Data suggest that antiarrhythmic prodrugs amiodarone and dronedarone are extensively metabolized by CYP2J2; specific CYP2J2 metabolites include N-desbutyldronedarone and N-desethylamiodarone, potent [reversible/irreversible] inhibitors of CYP2J2.
Tanshinone IIA exerts its anticancer effect by inhibiting CYP2J2 activity in HepG2 cells.
CYP2J2 expression showed significant upregulation (P<0.05) during Cy treatment before stem cell transplantation
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is thought to be the predominant enzyme responsible for epoxidation of endogenous arachidonic acid in cardiac tissue.
cytochrome P450, family 2, subfamily J, polypeptide 2
, hypothetical LOC530929
, cytochrome P450, family 2, subfamily J-like
, arachidonic acid epoxygenase
, cytochrome P450 2J2
, cytochrome P450, subfamily IIJ (arachidonic acid epoxygenase) polypeptide 2
, flavoprotein-linked monooxygenase
, microsomal monooxygenase